在急性心肌梗塞和其治疗潜力的巨极化动态调节

Anchen Xu1,2, Shuai Xu1,2, Xin Tan1,2

  • 1Department of Cardiology, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital, Medical Center of Soochow University, Suzhou, 215000, People's Republic of China.

PubMed
概括

巨细胞是急性心肌梗塞 (AMI) 的关键免疫细胞. 从M1 (炎症) 转移到M2 (修复) 的巨细胞极化是改善心脏病发作结果的有希望的治疗标.